A Turkish ophthalmologist’s experimental eye drop targeting Fuchs’ dystrophy, a corneal disease that can lead to blindness and currently has no treatment other than corneal transplantation, has shown promising results in animal studies and was awarded top scientific recognition at a major U.S. congress.